University Of Luebeck — Clinical Trial Site

14 Registered trials

3 Currently recruiting

Organisation

University Of Luebeck

Location

Luebeck, Germany

Identifier

ORG-100031253

Address

Ratzeburger Allee 160, Strecknitz, 23562, Germany

Departments

"Klinik fur Dermatologie, Allergologie und Venerologie, Institut fur Entzundungsmedizin"
Innere Medizin, SP Hämatologie und Internistische Onkologie
Klinik für Dermatologie
Klinik für Hämatologie und Onkologie
Klinik für Orthopädie und Unfallchirurgie
Medizinische Klinik II
N/A
Neurologie
Pädiatrische Hämatologie und Onkologie
Pediatric Hematology/Oncology
Universitaetsklinikum Schleswig Holstein - Campus Luebeck; Haematologie, Onkologie
Universitätsklinikum Schleswig-Holstein

Clinical trials at this site (14)

Search interface

A study to evaluate the efficacy of oxaliplatin- or gemcitabine-based chemotherapy after allocation by standard criteria or by genetic marke… Pending

2024-514682-19-00 Resected pancreatic ductal adenocarcinoma 5
A study to investigate improvement in pruritus of Lichen Simplex Chronicus with dupilumab injections compared with placebo in male and femal… Recruiting

2024-514737-37-00 Neurodermatitis 5 2025-03-06
A study to evaluate the efficacy and safety of subcutaneous amlitelimab on background topical corticosteroids therapy in participants aged 1… Recruiting

2023-508099-12-00 Dermatitis atopic 5 2024-06-20
ENhanced recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis after primary Hip Arthroplasty Recruiting

2023-507490-18-00 Patients undergoing elective unilateral primary hip art 5 2024-11-26
A Study to Comparing the Efficacy and Safety of Glofitamab (RO7082859) in Combination with Polatuzumab Vedotin Plus Rituximab, Cyclophospha… Ended

2023-504028-24-00 Large B-Cell Lymphoma 5 2023-09-22
Comparison of Carboplatin and Cisplatin in patients with extracranial malignant germ cell tumours Ended

2023-507582-25-00 Malignant Extracranial Germ Cell Tumours (MGCT) 5 2019-08-02
International multicenter, open-label clinical trial for the treatment of acute myeloid leukemia in children and adolescents Halted

2022-500783-35-00 Acute Myeloid Leukemia 5 2022-12-06
Effects of NNC0194-0499, cagrilintide, and semaglutide alone or in combinations on liver damage and alcohol use in people with alcohol-relat… Ended

2023-508170-28-00 alcohol-related liver disease 4 2024-08-07
REIMAGINE 2: A research study to see how well CagriSema compared to semaglutide, cagrilintide and placebo lowers blood sugar and body weight… Ended

2022-502678-18-00 Type 2 diabetes 5 2023-11-07
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight and Type 2 Diabetes (ATTAIN-2) Ended

2022-502837-24-00 Overweight 5 2023-09-25
A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (S… Ended

2022-501753-36-00 Hidradenitis Suppurativa 5 2023-06-02
A multicenter, randomized, double-blind, placebo-controlled TRial evaluating Immunosuppressive treatment in patients with chronic virus-Nega… Ended

2024-512451-20-00 Patients with biopsy-proven virus-negative inflammatory 10 2023-02-28
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Assess the Efficacy, Safety, Tolerability, PK, and Biomarker Effe… Ended

2023-510317-26-00 Amyotrophic Lateral Sclerosis 4 2023-02-07
Ramucirumab plus Irinotecan / Leucovorin / 5-FU versus Ramucirumab plus Paclitaxel in patients with advanced or metastatic adenocarcinoma of… Ended

2024-512934-14-00 advanced or metastatic adenocarcinoma of the stomach or 5 2016-11-07